artesunate vaginal insert
/ Frantz Viral Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 03, 2025
ART_CIN_II: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
(clinicaltrials.gov)
- P2 | N=78 | Recruiting | Sponsor: Frantz Viral Therapeutics, LLC | Trial completion date: Dec 2025 ➔ Dec 2026 | Trial primary completion date: Jul 2025 ➔ Jul 2026
Trial completion date • Trial primary completion date • Cervical Cancer • Gynecology • Human Papillomavirus Infection • Infectious Disease • Oncology
February 21, 2024
ART_CIN_II: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
(clinicaltrials.gov)
- P2 | N=78 | Recruiting | Sponsor: Frantz Viral Therapeutics, LLC | Trial completion date: Mar 2025 ➔ Dec 2025 | Trial primary completion date: Jul 2024 ➔ Jul 2025
Trial completion date • Trial primary completion date • Cervical Cancer • Gynecology • Human Papillomavirus Infection • Infectious Disease • Oncology
1 to 2
Of
2
Go to page
1